Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Description of key information

According to ECHA Guidance on the Application of the CLP Criteria (2015), Coriander oil can be classified as skin sensitizer based on its composition (Dipentene, Geraniol, Geranyl acetate, pinene alpha, pinene beta and terpinolene) classified as skin sensitizer Cat. 1B, above the generic concentration limit of 1%).

Key value for chemical safety assessment

Skin sensitisation

Link to relevant study records
Reference
Endpoint:
skin sensitisation, other
Remarks:
Classification based on calculation rules for mixtures of the CLP Regulation
Type of information:
calculation (if not (Q)SAR)
Adequacy of study:
key study
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
accepted calculation method
Qualifier:
no guideline required
Principles of method if other than guideline:
Classification based on calculation rules for mixtures of the CLP Regulation
Key result
Parameter:
other: Classification
Remarks on result:
other: Skin sensitiser category 1B
Interpretation of results:
Category 1B (indication of skin sensitising potential) based on GHS criteria
Conclusions:
Coriander oil obtained from seeds of Coriandrum sativum by steam distillation shall be classified as a skin sensitizer cat.1B without further testing based on calculation rules for mixtures according to the Regulation (EC) No 1272/2008 and the Directive 1999/45/EEC.
Executive summary:

The NCS is composed of several identified constituents and in that, it can be considered as a mixture according to the definition of the CLP Regulation. The decision logic for classification of mixtures from the ECHA Guidance on the Application of the CLP Criteria (2015) was used to determine the skin sensitising potential of the registered substance.

The registered substance has not been tested itself in appropriate in vitro or in vivo tests but some of its constituents are classified as skin sensitisers Cat.1B (Linalol, Dipentene, geraniol, geranyl acetate, pinene alpha, pinene beta, terpinolene) and are all potentially present above the CLP generic concentration limit of 1% that triggers classification of the mixture. Therefore, the registered substance is classified as a skin sensitiser Cat. 1B without further testing according to the Regulation (EC) No 1272/2008.

Endpoint conclusion
Endpoint conclusion:
adverse effect observed (sensitising)
Additional information:

The decision logic for classification of mixtures from the ECHA Guidance on the Application of the CLP Criteria (2015) was used to determine the skin sensitising potential of the registered substance.


 


The registered substance has not been tested itself in appropriate in vitro or in vivo tests but some of its constituents are classified as skin sensitisers 1B (Linalol, Dipentene, geraniol, geranyl acetate, pinene alpha, pinene beta and terpinolene) and are all present above the CLP generic concentration limit of 1% that triggers classification of the mixture.


Therefore, the registered substance is classified as a skin sensitiser 1B without further testing according to the Regulation (EC) No 1272/2008.

Respiratory sensitisation

Endpoint conclusion
Endpoint conclusion:
no study available

Justification for classification or non-classification

Harmonized classification:


The registered substance has no harmonized classification according to the Regulation (EC) No. 1272/2008.


 


Self-classification:


Based on the typical composition provided by the Lead Registrant, the registered substance is classified as skin sensitiser: Skin Sens. 1B, H317 (May cause an allergic skin reaction) according to the Regulation (EC) No. 1272/2008 (CLP).


 


No information was available regarding respiratory sensitisation.